DOC Stock Forecast & Price Target

Healthpeak Properties possesses a robust and diversified healthcare portfolio, comprising approximately 700 properties that span medical office, life science, senior housing, hospital, and skilled nursing/post-acute care assets, which enhances its stability and revenue generation potential. Recent trends in the healthcare sector, such as substantial increases in net sales for related firms like Seres and positive developments in trials like those from Vaxart, indicate a favorable environment for healthcare investments. Additionally, the expansion of the medical office building (MOB) portfolio by DOC, including new developments valued at $148 million with high pre-leasing rates and attractive projected yields, further solidifies the positive outlook for Healthpeak's operational growth and overall market position.

Healthpeak Properties's stock outlook has been downgraded due to increased credit risk associated with Lab tenants, which poses a downside threat to anticipated earnings for 2026. In addition, weak leasing performance in Q2 has led to a revised forecast of a compound annual growth rate (CAGR) for FFOPS/AFFOPS of +1%/-1% for the years 2026-2027, a decline from previous estimates of +2%/+1%. Furthermore, management indicated potential occupancy headwinds in the Lab sector in the second half of 2025, driven by sluggish capital raising efforts.